Skip to main content
logo
Foghorn Therapeutics Inc. (FHTX)
NASDAQ: FHTX · Real-Time Price · USD
6.05
+0.05 (0.83%)
At close: Jul 8, 2026, 4:00 PM EDT
5.72
-0.33 (-5.45%)
After-hours: Jul 8, 2026, 7:54 PM EDT

Foghorn Therapeutics Revenue

Foghorn Therapeutics had revenue of $3.27M in the quarter ending March 31, 2026, a decrease of -45.11%. This brings the company's revenue in the last twelve months to $28.22M, up 20.08% year-over-year. In the year 2025, Foghorn Therapeutics had annual revenue of $30.91M with 36.75% growth.

Revenue (ttm)
$28.22M
Revenue Growth
+20.08%
P/S Ratio
12.84
Revenue / Employee
$266,264
Employees
106
Market Cap
362.26M

Revenue Chart

Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 202530.91M8.31M36.75%
Dec 31, 202422.60M-11.55M-33.83%
Dec 31, 202334.16M14.93M77.63%
Dec 31, 202219.23M17.91M1,357.77%
Dec 31, 20211.32M889.00K206.74%
Dec 31, 2020430.00K--
Dec 31, 2019---
Dec 31, 2018---

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company NameRevenue
Fennec Pharmaceuticals51.00M
OmniAb28.94M
Zentalis Pharmaceuticals26.87M
Abeona Therapeutics14.54M
X4 Pharmaceuticals9.01M
Fate Therapeutics6.32M
Lyell Immunopharma31.00K
Inhibikase Therapeutics1.00
Revenue Rankings

FHTX News

More News